Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  bupropion hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-17 of 17 for your search:
Start Over
Wellbutrin XL, Major Depressive Disorder and Breast Cancer
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Prot105042, 29000-J08101, NCT00234195
STOP Study: Effectiveness of Zyban in a Clinical Population
Phase: Phase IV
Type: Behavioral study, Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 005/2008, NCT01015170
The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia
Phase: Phase IV
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 16 to 65
Sponsor: Other
Protocol IDs: MD-095-PP-05A, NCT00495352
Smoking Cessation for Veterans With Severe and Persistent Mental Illness
Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: NURA-001-09S, NCT00960375
Pharmacogenetics, Emotional Reactivity and Smoking
Phase: Phase III, Phase II
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: 2003-1024, 1R01DA017073, NCI-2012-02108, NCT00507728
Varenicline and Bupropion for Smoking Cessation
Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 09-003598, 09-002459, 1RO1CA138417, NCT00935818
Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking
Phase: Phase III
Type: Behavioral study
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069303, NCCTG-N99C4, NCI-P02-0220, NCT00033592
Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype
Phase: Phase III
Type: Behavioral study, Prevention
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: Pro00013846, NCT00894166
Combining Varenicline and Bupropion for Smoking Cessation
Phase: Phase III
Type: Educational/Counseling/Training, Prevention
Status: Closed
Age: 25 to 65
Sponsor: NCI, Other
Protocol IDs: 2008-0850, R01DA024709-01A1, NCI-2011-01101, NCT00943618
Smoking Cessation for American Indians
Phase: Phase III
Type: Behavioral study, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 11862, R01 CA141618, NCT01106456
Bupropion in Helping Adults Stop Smoking
Phase: Phase II
Type: Behavioral study, Educational/Counseling/Training, Prevention
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: CDR0000565103, I 57805, RPCI-I-57805, NCT00534001
Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 2: Do Varenicline (Chantix) and Bupropion (Zyban) Change Alcohol Drinking?
Phase: Phase II
Type: Behavioral study, Prevention
Status: Closed
Age: 21 and over
Sponsor: Other
Protocol IDs: HIC0702002391, R01AA015596-01, NCT00580645
Randomized Study of Behavioral Training With Versus Without Bupropion for Smoking Cessation and the Prevention of Relapse in Participants Who Are Current Smokers
Phase: No phase specified
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SUMC-74511
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
Phase: No phase specified
Type: Behavioral study, Biomarker/Laboratory analysis, Educational/Counseling/Training, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 10332, R01CA091912, KUMC-HSC-10332, KUMC-070313, NCT00666978
Nicotine Patch Pretreatment for Smoking Cessation in PTSD
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: NEUA-007-07F, NCT00625131
Integrated Smoking Cessation Treatment for Low Income Community Corrections
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Completed
Age: 19 to 80
Sponsor: NCI, Other
Protocol IDs: R01CA141663, R01CA141663-01, NCT01257490
Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke
Phase: No phase specified
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, NIH WGMCC
Protocol IDs: 999903308, 03-C-N308, CDR0000356037, NCI-03-C-N308, NCT00079469
Start Over